M Craig Miller

Title: Innovations by M Craig Miller

Introduction

M Craig Miller is a notable inventor based in Guthrie, Oklahoma, recognized for his contributions to the field of medical technology, particularly in the area of prostate cancer diagnosis and prognosis. With two registered patents to his name, Miller has developed innovative methods aimed at enhancing cancer screening processes, providing significant advancements in patient care.

Latest Patents

Miller's latest patents include sophisticated techniques for predicting prostate cancer progression. One of his inventions outlines a method for screening individuals at risk for prostate cancer recurrence following surgical intervention. This method employs specific Markovian nuclear texture factors alongside other biomarkers to ascertain whether the cancer is likely to progress or remain confined. Further, it introduces a neural network to analyze cell morphology data, allowing for predictive analytics based on training data from known cases of cancer progressors and non-progressors.

Another significant patent focuses on a sextant core biopsy predictive mechanism for non-organ confined disease. Similar to his earlier patent, it facilitates the evaluation of patients’ cells to determine the risk of losing organ confinement. Through the statistical analysis of selected biomarkers, as well as the incorporation of advanced neural network methodologies, this invention aims to predict the loss of organ confinement in prostate cancer patients more effectively.

Career Highlights

M Craig Miller has had the opportunity to work with reputable institutions such as the University of Tulsa and The Johns Hopkins University. Through his innovative research and patent development, he has made substantial contributions to cancer research, significantly impacting how prostate cancer is diagnosed and treated.

Collaborations

Throughout his career, Miller has collaborated with esteemed professionals in his field, including Robert W. Veltri and Michael P. Bacus. Their collective efforts and expertise helped propel the development of advanced diagnostic techniques that can alter patient outcomes in prostate cancer treatment.

Conclusion

M Craig Miller’s innovative work exemplifies the impact of research and invention in the medical field. His patents not only enhance the understanding of prostate cancer progression but also improve screening methods, thereby contributing to the future of oncological care. Through his career, he has shown the profound role that inventors play in advancing healthcare technology and patient welfare.